Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Outpatient colchicine poisoning

R S Hoffman1, R D Shih, J M Baruch

  • 1New York City Poison Control Center.

Delaware Medical Journal
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A response to Zhou et al., regarding thiamine supplementation in altered mental status.

Hospital practice (1995)·2022
Same author

Authors' response to: "Beta-blocker treatment of caffeine-induced tachydysrhythmias".

Clinical toxicology (Philadelphia, Pa.)·2016
Same author

Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018.

Clinical pharmacology and therapeutics·2015
Same author

Retained drugs in the gastrointestinal tracts of deceased victims of oral drug overdose.

Clinical toxicology (Philadelphia, Pa.)·2014
Same author

A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid.

Clinical toxicology (Philadelphia, Pa.)·2014
Same author

Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroup.

Clinical toxicology (Philadelphia, Pa.)·2014

Colchicine effectively treats gout attacks but carries significant toxicity. Poor doctor-patient communication can dangerously exacerbate risks associated with this potent medication.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Patient Safety

Background:

  • Colchicine is a well-established treatment for acute gouty arthritis.
  • The drug possesses a narrow therapeutic index, indicating a high risk of toxicity.
  • Previous literature extensively documents both its efficacy and adverse effects.

Observation:

  • This case report details a nonfatal incident involving colchicine toxicity.
  • The event highlights the critical role of clear communication between physicians and patients.
  • Inadequate communication regarding the risks of highly toxic medications was a key factor.

Findings:

  • Colchicine toxicity can manifest even in nonfatal cases.
  • Effective patient education is crucial when prescribing medications with a low therapeutic index.

Related Experiment Videos

  • Communication breakdowns can lead to adverse patient outcomes.

    • Implications:

    • Healthcare providers must emphasize the dangers of colchicine and similar toxic drugs.
    • Enhanced doctor-patient dialogue is essential for safe medication management.
    • This case underscores the need for improved protocols in communicating medication risks.